Abstract:Objective To observe the effect and safety of methotrexate in patients with ectopic pregnancy with different serum human chorionic gonadotropin (β-hCG) trends.Methods Ninty patients with ectopic pregnancy were selected from January 2019 to October 2020 in Hainan Modern Women and Children's Hospital and divided into the β-hCG high value group (β-hCG ≥ 3 000 u/L, 55 cases) and the β-hCG low value group (β-hCG < 3 000 u/L, 35 cases) according to the changes of β-hCG 24h before treatment. All patients were given methotrexate 50 mg/m2 intramuscularly. The treatment effect, β-hCG recovery, disappearance of ectopic pregnancy masses, progesterone, estrogen, and adverse reactions were observed.Results The total clinical effective rate in the β-hCG high value group was higher than that in the β-hCG low value group, and the difference was statistically significant (P < 0.05). The recovery time of β-hCG and the disappearance time of ectopic pregnancy mass in the β-hCG high value group were shorter than those in the β-hCG low value group, after 7 days of treatment, the diameters of β-hCG and ectopic pregnancy mass were lower than those in the β-hCG low value group, and the difference was statistically significant (P < 0.05). There was no significant difference in the incidence of total adverse reactions between the two groups (P > 0.05).Conclusion Compared to low value β- HCG patients, the clinical effect of ectopic pregnancy patients with high β-hCG was better after receiving methotrexate treatment.